Chemed (NYSE:CHE) CEO Kevin Mcnamara Sells 2,000 Shares of Stock

Chemed Corporation (NYSE:CHE) CEO Kevin Mcnamara sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $541.16, for a total transaction of $1,082,320.00. Following the sale, the chief executive officer owned 70,418 shares of the company’s stock, valued at $38,107,404.88. The trade was a 2.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Chemed Trading Down 0.1%

NYSE:CHE opened at $540.18 on Tuesday. The stock has a market cap of $7.06 billion, a PE ratio of 27.13, a price-to-earnings-growth ratio of 2.05 and a beta of 0.51. The stock’s 50-day moving average is $501.57 and its two-hundred day moving average is $447.26. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.91 and a quick ratio of 0.89. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $557.00.

Chemed (NYSE:CHE) last issued its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46. The business had revenue of $673.25 million for the quarter, compared to analyst estimates of $665.04 million. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The firm’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, equities research analysts forecast that Chemed Corporation will post 23.18 earnings per share for the current fiscal year.

Chemed Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Monday, August 17th will be issued a dividend of $0.70 per share. This is an increase from Chemed’s previous quarterly dividend of $0.60. The ex-dividend date of this dividend is Monday, August 17th. This represents a $2.80 annualized dividend and a dividend yield of 0.5%. Chemed’s payout ratio is currently 14.06%.

Institutional Trading of Chemed

Several institutional investors and hedge funds have recently modified their holdings of the business. California State Teachers Retirement System raised its holdings in Chemed by 45,134.8% in the 2nd quarter. California State Teachers Retirement System now owns 7,613,918 shares of the company’s stock valued at $3,546,106,000 after buying an additional 7,597,086 shares during the last quarter. Northwestern Mutual Wealth Management Co. increased its position in shares of Chemed by 2,444,879.3% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company’s stock valued at $2,374,667,000 after buying an additional 5,549,876 shares during the period. BlackRock Inc. bought a new position in Chemed in the second quarter worth $691,290,000. Norges Bank purchased a new position in Chemed during the fourth quarter valued at $76,067,000. Finally, AQR Capital Management LLC boosted its holdings in shares of Chemed by 89.2% during the 4th quarter. AQR Capital Management LLC now owns 325,579 shares of the company’s stock valued at $139,302,000 after buying an additional 153,469 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the stock. Bank of America restated a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. Weiss Ratings raised shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Wall Street Zen upgraded Chemed from a “hold” rating to a “strong-buy” rating in a report on Saturday, August 1st. Finally, Royal Bank Of Canada lifted their target price on Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a report on Thursday, July 30th. One research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $530.75.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.